SY NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

So-Young International Inc · Healthcare · Health Information Services

Latest close 1.93 USD
14.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -23.6% below the Trend Line and sits at 16.0% of its 52-week range. The latest completed week returned 14.9%, after a 35.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is inexpensive relative to peers. Options positioning is volatility with 65/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 22d.

Setup score 29 out of 100
Latest Close 1.93 USD 24 Jul 2026
1W Return 14.9% latest completed week
4W Return 35.9% short-term follow-through
12W Return -35.7% quarterly tape
Trend Breadth 36.5% 19 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -23.6% below the Trend Line and sits at 16.0% of its 52-week range. The latest completed week returned 14.9%, after a 35.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0212-week average 0.05

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.02Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 35.9% over four weeks, -35.7% over 12 weeks, and -58.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W14.9%
4W35.9%
12W-35.7%
26W-33.2%
52W-58.4%
Active trend streak0 weeks
Active weeks in one year19
Trend breadth36.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.20Latest activity-pressure read.
Pressure change21.3%Four-week change in activity pressure.
Leadership-41.40Latest relative-leadership reading.
RS change32.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength47/100Blend of value, momentum, and quality. Underlying universe rank 54; rank 1 is best.
Value90/100Relative valuation strength. Underlying universe rank 11; rank 1 is best.
Quality9/100Profitability and accounting quality. Underlying universe rank 92; rank 1 is best.
Momentum3/100Medium-term price momentum. Underlying universe rank 98; rank 1 is best.
Growth75/100Revenue and earnings growth. Underlying universe rank 26; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.1x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
41.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
46.0%
Gross profit retained from each unit of revenue.
Operating margin
-20.3%
Operating profit retained from revenue.
Free-cash-flow margin
5.5%
Free cash flow generated from revenue.
Return on invested capital
-17.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
14.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
9.8%
Cash dividends relative to market value.
Buyback yield
7.9%
Net share repurchases relative to market value.
Shareholder yield
17.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

SY shows volatility options pressure with a 65/100 conviction score, put-call volume ratio of n/a, expected move of 32.6%, and Sharemaestro trend signal inactive.

Conviction65/100
Expected move32.6%
Put/call volume
Pressure-100
Speculation0
Volatility96
Trend agreement52
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 24 relevant articles.

7 positive · 11 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings22dNext report is scheduled for 21 Aug 2026; event risk rises as the date approaches.
Options expected move32.6%Nearest-chain priced movement where available.
52-week drawdown-63.9%Distance below the 52-week high.
13-week volatility11.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher7 of 2618 weeks finished lower.
Best week+18.3%Week of 6 Feb.
Worst week-23.4%Week of 19 Jun.
Latest week+14.9%Week of 24 Jul.

Shape of recent returns

Strong gains7
Modest gains0
Flat weeks1
Modest losses11
Sharp losses7
Recent vol11.4%13-week weekly-return volatility.
Base vol11.9%52-week weekly-return volatility.
Up/down split17/34Count of positive and negative weeks in the 52-week window.
Average skew10.5% / -6.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20261.93 USD14.9%2.53 USD1.70 USD-1.20-41.40918.1KOff
17 Jul 20261.68 USD-1.8%2.55 USD1.70 USD-1.35-50.871.0MOff
10 Jul 20261.71 USD11.0%2.59 USD1.70 USD-1.48-53.541.3MOff
3 Jul 20261.54 USD8.5%2.63 USD1.69 USD-1.53-58.132.2MOff
26 Jun 20261.42 USD-0.4%2.69 USD1.69 USD-1.53-61.593.5MOff
19 Jun 20261.43 USD-23.4%2.74 USD1.70 USD-1.50-63.501.7MOff
12 Jun 20261.86 USD-3.6%2.79 USD1.70 USD-1.41-51.142.7MOff
5 Jun 20261.93 USD-1.0%2.85 USD1.70 USD-1.23-47.994.1MOff
29 May 20261.95 USD-12.6%2.94 USD1.70 USD-0.91-49.635.8MOff
22 May 20262.23 USD-21.8%2.97 USD1.70 USD-0.61-40.516.1MOff
15 May 20262.85 USD-4.0%2.99 USD1.69 USD-0.42-22.642.3MOff
8 May 20262.97 USD-1.0%3.00 USD1.69 USD-0.26-18.921.9MOff
1 May 20263.00 USD10.3%3.02 USD1.68 USD-0.32-12.801.8MOff
24 Apr 20262.72 USD-3.9%3.04 USD1.68 USD-0.22-18.871.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.